1 December 2019 - The December 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are several major new listings this month:

• Alectinib hydrochloride (Alecensa) - new medicine
• Meningococcal Groups A, C, W135 & Y conjugate vaccine (Menactra) - new indication
• Ocrelizumab (Ocrevus) - new medicine
• Pirfenidone (Esbriet) - restriction change
• Trastuzumab emtansine (Kadcyla) - new medicine
• Venetoclax (Venclexta) - new medicine

Read New Zealand Pharmaceutical Schedule update